Join to access to all OVN content. Join for Free

Results for 'pre-clinical'

Find oncology podcasts about pre-clinical — interviews, panel discussions, and expert-led audio on cancer innovation. Open any episode for listening options and show notes; switch tabs to explore articles, partners, and community members.

Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray
Partner Avatar Monty Pal
Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray

City of Hope, Academic Research, precision medicine, AI

In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Stacy Gray, M.D., A.M., Director of Clinical and Scientific Strategy and Vice President of System Strategy at City of Hope, joins Monty Pal, M.D., F.A.S.C.O. in an engaging discussion of how precision medicine and AI are tran…

Feb 23rd • 43 mins listen

Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
Partner Avatar Jesus Izaguirre-Carbonell
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing

Quest, Diagnostics, MRD, minimal residual testing, precision, biomarker

Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.

Jul 7th • 19 mins listen

Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery
Partner Avatar Monty Pal
Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery

City of Hope, Academic Research, ASCO, precision, AI, dose strategy

Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.

Jun 23rd • 43 mins listen

Tumor-Agnostic Therapies and the Future of HER2 in Oncology
Partner Avatar Rebecca Previs
Tumor-Agnostic Therapies and the Future of HER2 in Oncology

diagnostic, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker

What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.

Jun 8th • 20 mins listen

FFPE: The Workhorse Behind NGS Testing
Partner Avatar Rebecca Previs
FFPE: The Workhorse Behind NGS Testing

biomarker, sequencing, diagnostics, translational research, precision

Exploring FFPE’s impact on precision oncology, NGS innovation, and the future of tissue stewardship in cancer care with leading Labcorp experts.

Jan 28th • 33 mins listen

How Cross-Functional Teams Reshape Cancer Care
OVN Avatar Kirk Shepard
How Cross-Functional Teams Reshape Cancer Care

Jay Fine, Preclinical Research, Early Stage

In episode 3 of Oncology Voice Network Podcast, Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.

Feb 17th • 23 mins listen

The Long Game of Cancer Genomics: John Carpten, Ph.D., on Building Precision Oncology that Reaches Patients
Partner Avatar Monty Pal
The Long Game of Cancer Genomics: John Carpten, Ph.D., on Building Precision Oncology that Reaches Patients

City of Hope, Academic Research, genomics, genome mapping, TGen, Translational Genomics Research Institute, spatial biology, AI, access

In this episode of On the Edge of Breakthrough: Voices of Cancer Research, John Carpten, Ph.D., Chief Scientific Officer at City of Hope, discusses the evolution of cancer genomics—how early genome mapping enabled today’s targeted approaches and what infrastructure and equity considerations will…

Mar 23rd • 56 mins listen

Aspiring MSL Insight: Do You Have a Back-Pocket Presentation?
Partner Avatar Michael Pietrack
Aspiring MSL Insight: Do You Have a Back-Pocket Presentation?

If you’re an aspiring MSL, you’re probably thinking a lot about how to master the MSL interview. 🎤 The biggest part of the interview is the presentation you’ll give during the final interview. 📊 One way to really shine on this very important element of the evaluation process …

Jul 22nd • 3 mins listen

Aspiring MSL Insight: What Types of MSL Presentations are Acceptable in a Final Interview?
Partner Avatar Michael Pietrack
Aspiring MSL Insight: What Types of MSL Presentations are Acceptable in a Final Interview?

Aspiring MSL Insight: What Types of MSL Presentations are Acceptable in a Final Interview? 🧑‍⚕️🎤 If you’re an Aspiring MSL, you likely realize how important the MSL presentation is during the final interview. But you may be wondering, “What type of presentation should…

Aug 9th • 3 mins listen

IO Clinical Trials During COVID-19
OVN Avatar Cancer Buzz Podcast
IO Clinical Trials During COVID-19

On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials. Guest: Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive …

Jun 23rd • 13 mins listen

The Importance of Reading Clinical Trial Protocols Simultaneously With Published Studies
OVN Avatar Journal of Clinical Oncology (JCO) Podcast
The Importance of Reading Clinical Trial Protocols Simultaneously With Published Studies

This podcast discusses whether the primary outcomes and study design for the reported trial were properly pre-specified and pre-registered prior to accruing participants.

Jan 24th • 12 mins listen

Address Knowledge Gaps in Evidence-Based Precision Medicine Care
OVN Avatar The Oncology Nursing Podcast
Address Knowledge Gaps in Evidence-Based Precision Medicine Care

ONS member Kristi Orbaugh, RN, MSN, RNP, AOCN®, nurse practitioner for Community Hospital Oncology Physicians in Indianapolis, IN, and member of the Central Indiana ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss knowledge gaps in clinical practic…

Mar 29th • 40 mins listen

The Pulse of the Oncologist: Listening to What Matters Most
Partner Avatar
The Pulse of the Oncologist: Listening to What Matters Most

diagnostic, digital, molecular residual disease, MRD

Pulse of the Oncologist survey reveals trends in cancer diagnostics, digital solutions, care barriers, and the innovations transforming oncology today.

Apr 14th • 22 mins listen

How Engineered Antibodies and Next Generation Imaging Tools are Reshaping Cancer Care with Anna Wu, Ph.D.
Partner Avatar Monty Pal
How Engineered Antibodies and Next Generation Imaging Tools are Reshaping Cancer Care with Anna Wu, Ph.D.

City of Hope, Academic Research, engineered antibodies, PET, imaging, radioisotope, CEA directed agent, PSCA targeted radiopharmaceutical, pancreatic cancer, prostate cancer

In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Anna Wu, Ph.D., Chair of the Department of Immunology and Theranostics at City of Hope, joins host Monty Pal, M.D., for an engaging discussion on how innovations in antibody engineering and imaging are improving clinicians’…

Mar 9th • 42 mins listen

Humans Beyond the Algorithm: Hiring for Oncology’s Future
OVN Avatar Kirk Shepard
Humans Beyond the Algorithm: Hiring for Oncology’s Future

Stacy Benefiel, AI, Talent, Workforce Innovation, Human Resources, HR

In episode 4 of Oncology Voice Network Podcast, Host Dr. Kirk Shepard welcomes Stacey Benefiel, PharmD, Head of Global Clinical and Medical Affairs at Canopy, for a candid exploration of what it really takes to build the future oncology workforce.

Mar 3rd • 23 mins listen

Breaking Barriers in Cancer Care: Expanding Access, Innovation & Integrative Medicine
Partner Avatar Monty Pal
Breaking Barriers in Cancer Care: Expanding Access, Innovation & Integrative Medicine

City of Hope, Academic Research, integrative oncology, patient access

Dr. Ed Kim shares insights on why redefining the standard of care is critical for improving patient outcomes, the future of clinical trials, and the role of integrative medicine in oncology.

Mar 21st • 33 mins listen

Why Genetic Testing Should Be Standard in Prostate Cancer
Partner Avatar Rebecca Previs
Why Genetic Testing Should Be Standard in Prostate Cancer

diagnostic, genetic counselor, genetic testing, prostate cancer, urologic oncology, digital

Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.

May 18th • 19 mins listen

Rethinking How We Track and Treat Cancer
Partner Avatar Rebecca Previs
Rethinking How We Track and Treat Cancer

diagnostic, genomics, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, biomarker

HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.

Jul 13th • 19 mins listen

Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
Partner Avatar Rebecca Previs
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy

diagnostic, breast cancer, digital, biomarker, genetic testing, advocacy

Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.

Oct 19th • 26 mins listen

ctDNA Breakthroughs in Mesothelioma Care
Partner Avatar Rebecca Previs
ctDNA Breakthroughs in Mesothelioma Care

diagnostic, immunotherapy, imaging

Exploring immunotherapy and ctDNA innovation in mesothelioma, where molecular monitoring may redefine early cancer detection and treatment.

Nov 3rd • 15 mins listen

Related Topics

Meet Our Innovation Partners

Loading partners...